Applied Genetic Technologies Corporation
AGTCNASDAQHealthcare
$0.39
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$2.825
52W Low$0.2303
Applied Genetic Technologies Corporation (AGTC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AGTC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-06 | 2021-06 | 2020-06 | 2019-06 | 2018-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.33M | $0.50M | $2.45M | $41.69M | $24.19M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.33M | $0.50M | $2.45M | $41.69M | $24.19M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $49.52M | $44.40M | $35.78M | $33.18M | $32.18M |
| G&A Expenses | $16.98M | $14.55M | $13.62M | $12.86M | $14.39M |
| Total Operating Expenses | $66.50M | $58.95M | $49.40M | $46.04M | $46.57M |
| Operating Income | ($66.27M) | ($58.45M) | ($46.94M) | ($4.35M) | ($22.38M) |
| Operating Margin %(computed) | — | — | — | -10.43% | -92.55% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.67M | $1.51M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($68.75M) | ($59.94M) | ($45.81M) | ($1.90M) | ($21.21M) |
| Income Tax Expense | $2.67M | ($2.11M) | $0.08M | $0.08M | $0.07M |
| Net Income | ($71.42M) | ($57.83M) | ($45.89M) | ($2.01M) | ($21.30M) |
| Net Margin %(computed) | — | — | — | -4.81% | -88.07% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.59 | $-1.77 | $-2.17 | $-0.11 | $-1.18 |
| Wtd Avg Shares | 45.03M | 32.76M | 21.10M | 18.16M | 18.11M |
| EBITDA | ($64.76M) | ($56.97M) | ($46.94M) | ($4.35M) | ($20.05M) |
| EBITDA Margin %(computed) | — | — | — | -10.43% | -82.91% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Applied Genetic Technologies Corporation data
About Applied Genetic Technologies Corporation (AGTC) Income Statement
Applied Genetic Technologies Corporation (AGTC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, AGTC reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.07B) — a net profit margin of -21976.62%.
Frequently asked questions
AGTC · 4 questionsApplied Genetic Technologies Corporation (AGTC) reported revenue of $0.00B for 2022, down 35.0% year-over-year.
AGTC revenueAGTC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09